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Randomized clinical trial of remote ischaemic preconditioning
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Background: Remote ischaemic preconditioning (RIPC) has been suggested as a means of protecting
vital organs from reperfusion injury during major vascular surgery. This study was designed to determine
whether RIPC could reduce the incidence of perioperative myocardial infarction (MI) during open
surgery for ruptured abdominal aortic aneurysm (AAA). Secondary aims were to see if RIPC could reduce
30-day mortality, multiple organ failure, acute intestinal ischaemia, acute kidney injury and ischaemic
stroke.
Methods: This randomized, non-blinded clinical trial was undertaken at three vascular surgery centres
in Denmark. Patients who had open surgery for ruptured AAA were randomized to intervention with
RIPC or control in a 1 : 1 ratio. Postoperative complications and deaths were registered, and ECG and
blood samples were obtained daily during the hospital stay.
Results: Of 200 patients randomized, 142 (72 RIPC, 70 controls) were included. There was no difference
in rates of perioperative MI between the RIPC and control groups (36 versus 43 per cent respectively), or
in rates of organ failure. However, in the per-protocol analysis 30-day mortality was significantly reduced
in the RIPC group (odds ratio 0⋅46, 95 per cent c.i. 0⋅22 to 0⋅99; P = 0⋅048).
Conclusion: RIPC did not reduce the incidence of perioperative MI in patients undergoing open surgery
for ruptured AAA. Registration number: NCT00883363 (http://www.clinicaltrials.gov).
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Introduction
Ruptured abdominal aortic aneurysm (AAA) is associated
with high morbidity and mortality rates. Perioperative
mortality ranges from 25 to 50 per cent, and rates of
myocardial and intestinal ischaemia are high, in the region
of 40 and 18 per cent respectively1–3.
Within the past 20 years there has been a focus on
the importance of ischaemia–reperfusion injury follow-
ing periods of low or completely abolished perfusion,
particularly of the myocardium. Several studies4–6 have
shown that, by inducing repeated transient ischaemia and
subsequent reperfusion of an organ or extremity, it is pos-
sible to protect vital organs from ischaemia–reperfusion
injury. This is the principle behind remote ischaemic pre-
conditioning (RIPC).
Patients undergoing coronary bypass surgery with
induced RIPC in an upper extremity had a total reduc-
tion in levels of troponin by 43 per cent when measured
by area under the curve, reflecting reduced perioper-
ative myocardial ischaemia7. The effects of RIPC in
vascular surgery have been described previously8–10.
© 2018 The Authors. BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd BJS Open 2018; 2: 112–118
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Potential eligible patients in national registry
diagnosed with ruptured AAA n=403
Allocated to RIPC n=100
Underwent RIPC n=72
Excluded
 Died before operation started n=17
 Died before vascular reconstruction completed n=9
 No consent n=0
 Technical problems with carrying out RIPC n=1
 Misinterpretation of RIPC instructions n=1
Randomized n=200
Lost to follow-up for primary outcome n=0 Lost to follow-up for primary outcome n=0
Analysed n=72
Excluded from analysis n=0
Analysed n=70
Excluded from analysis n=0
Allocated to standard procedure (control) n=100
Underwent standard procedure n=70
Excluded
 Died before operation started n=22
 Died before vascular reconstruction completed n=4
 No consent n=0
 Mycotic aneurysm and reconstructed with
 axillobifemoral bypass n=1
 Symptomatic and not ruptured AAA n=3
Not included n=203*
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Fig. 1 Flow chart for the study. *Mostly owing to problems with starting study protocol. AAA, abdominal aortic aneurysm; RIPC,
remote ischaemic preconditioning
One randomized study11 showed that RIPC of the
lower extremities during elective aortic surgery reduced
the myocardial infarction (MI) rate from 27 to 5 per
cent, and demonstrated a significant reduction in
renal damage.
Despite the significant interest in clinical effects of RIPC,
few randomized trials have been conducted, and none
solely on patients admitted for the treatment of ruptured
AAA. This study therefore sought to determine whether
RIPC during surgery for ruptured AAA could reduce
the incidence of MI. Secondary endpoints were 30-day
mortality, and rates of multiple organ failure, intesti-
nal ischaemia, acute kidney injury requiring dialysis, and
ischaemic stroke.
Methods
This randomized, non-blinded clinical trial included
patients with ruptured AAA. All patients were admitted
to Aarhus University Hospital, Aalborg University Hos-
pital or Kolding Hospital, Denmark, from April 2009 to
December 2014. The study was conducted according to the
CONSORT guidelines12 and registered at clinicaltrial.gov
(NCT00883363). Informed consent was obtained after
the operation, either from the patient or immediate rel-
atives, according to ethical guidelines for acute studies
in Denmark. The trial was performed in accordance
with the Declaration of Helsinki, and the International
Conference on Harmonization – Good Clinical Prac-
tice. The study was approved by the local research ethics
committee.
Randomization
All patients evaluated as capable of undergoing open repair
for ruptured AAA were included and randomized in a 1 : 1
ratio to either preconditioning after commencement of
anaesthesia or a control group. In a per-protocol analy-
sis, patients who died before vascular reconstruction were
excluded from the analysis, as well as any patients who did
not provide signed informed consent.
Randomization took place as soon as patient trans-
fer or admission was made known, often before the
patient was evaluated clinically by the vascular surgery
staff. Randomization was performed by use of sealed
envelopes with instructions regarding intervention. The
© 2018 The Authors. www.bjsopen.com BJS Open 2018; 2: 112–118
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Table 1 Participant characteristics
RIPC group Control group
(n=72) (n=70)
Age (years)* 72⋅3(8⋅6) 72⋅9(8⋅1)
Sex ratio (M : F) 63 : 9 64 : 6
BMI (kg/m2)† 26⋅7 (25⋅3, 28⋅0) 28⋅3 (27⋅2, 29⋅4)
Smoker
Yes 39 (54) 30 (43)
No 24 (33) 29 (41)
Unknown 9 (13) 11 (16)
Previous medical record‡
Ischaemic heart disease 20 (28) 15 (21)
Myocardial infarction 15 (21) 13 (19)
CABG/PCI 9 (13) 16 (23)
Stroke/TCI 8 (11) 9 (13)
Vascular surgery 3 (4) 2 (3)
Diabetes 5 (7) 8 (11)
Atrial fibrillation 10 (14) 11 (16)
COLD 11 (15) 12 (17)
Cancer 1 (1) 7 (10)
Hypertension 40 (56) 47 (67)
Preoperative medication
Antiplatelet 29 (40) 23 (33)
Anticoagulant 3 (4) 3 (4)
Lipid-lowering 29 (40) 28 (40)
Values in parentheses are percentages unless indicated otherwise; values
are *mean(s.d.) and †mean (95 per cent c.i.). ‡The previous medical
record was unknown for six patients (3 in each group). RIPC, remote
ischaemic preconditioning; CABG, coronary artery bypass grafting; PCI,
percutaneous coronary intervention; TCI, transient cerebral ischaemia;
COLD, chronic obstructive lung disease.
Table 2 Operative data
RIPC group Control group
(n=72) (n=70) P†
Duration of operation (min) 173(73) 175(70) 0⋅845
Autologous transfusion (ml) 993(984) 1439(1850) 0⋅427
Red blood cell transfusion (units) 8⋅7(6⋅7) 9⋅3(6⋅8) 0⋅628
Plasma (units) 5⋅5(3⋅3) 6⋅2(4⋅5) 0⋅354
Platelets (units) 1⋅8(1⋅3) 2⋅2(1⋅6) 0⋅203
Bifurcated prosthesis* 35 (49) 31 (44) 0⋅364‡
Values are mean(s.d.) unless indicated otherwise; *values in parentheses
are percentages. RIPC, remote ischaemic preconditioning.
†Mann–Whitney U test, except ‡χ2 test.
randomization key was done by computer program with
block randomization of 20 blocks of ten patients.
Intervention
RIPC was carried out by using a conventional BP cuff as a
tourniquet. This was placed on an upper arm of the patient
and inflated to 50 mmHg above systolic BP, or at least 175
mmHg. The inflation period lasted 5 min and was repeated
four times, with 5-min interruptions between inflations.
This intervention protocol for applying RIPC has been
commonly used13. In the control group, the cuff was used
in a conventional way simply for measurement of BP.
Aneurysm repair technique, anaesthesia and trans-
fusion were at the discretion of the attending physicians,
according to national and local hospital guidelines, and
surgery was performed by vascular surgeons. The interven-
tion started when the anaesthesia and surgical procedure
allowed it. The goal was to initiate RIPC before the aortic
clamp was set, and finish before the distal anastomosis
was completed. RIPC was postponed until after induction
of anaesthesia so that initial resuscitation or induction of
anaesthesia was not compromised.
Preconditioning was defined according to the European
Society of Cardiology14.
Blinding
Interventions were initialized and carried out by the anaes-
thetic team, but were not blinded to the surgeon. Sub-
sequent data collection was performed blinded. After all
data had been recovered and validated, the database was
locked and the randomization codes revealed.
Data collection
During the operation and intensive care stay, all patients
were monitored for myocardial ischaemia by real-time,
five-lead continuous ECG and oxygen saturation. After the
operation, and for the next 5 days, 12-lead ECG was carried
out and troponin T serum samples were collected daily.
If the patient experienced chest pain or any other clinical
symptoms of MI, an urgent ECG as well as troponin T
sample were obtained, and repeated after 6 and 12 h.
Outcomes
All complications were registered on case report forms
during the hospital stay. After completion of the study,
all journals were reviewed by a single author to ensure
complete capture of all events that occurred during the
study period. Dates of death were confirmed from the
Danish national personal registry.
In accordance with the 2007 consensus definition of
the European Society of Cardiology/American Heart
Association15, MI was defined by a troponin T increase
above the 99th percentile (corresponding to a level exceed-
ing 50 ng/l) with either ECG changes compatible with
ischaemia or the development of left bundle branch block
and/or typical chest pain. MI was diagnosed during the
hospital admission or during review of the clinical records,
and then confirmed by two members of the trial team.
© 2018 The Authors. www.bjsopen.com BJS Open 2018; 2: 112–118
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Fig. 2 Forest plot showing effect of remote ischaemic preconditioning versus standard treatment on myocardial infarction and secondary
endpoints. Odds ratios are shown with 95 per cent confidence intervals on a logarithmic scale for the per-protocol analysis
Secondary outcomes included: 30-day mortality; multi-
ple organ failure, defined as dysfunction of two or more
organ systems; kidney injury, defined as a need for either
temporary or permanent dialysis; stroke, defined as either
ischaemic stroke or cerebral haemorrhage (all patients sus-
pected of stroke underwent CT to exclude haemorrhage);
and intestinal ischaemia, defined by surgical removal of
ischaemic bowel.
Statistical analysis
Sample size determination was based on previous publica-
tions related to randomized RIPC interventions. Ali and
colleagues11 showed a reduction in the frequency of peri-
operative MI from 27 to 5 per cent (absolute risk reduction
22 per cent), corresponding to a relative risk reduction of
80 per cent. A conservative estimate placed the risk of MI
at 30 per cent in the control group of the present study. To
demonstrate a relative risk reduction of 50 per cent (inci-
dence 15 per cent in the RIPC group) with 80 per cent
power at a significance value of 0⋅05, 190 patients were
deemed necessary, so 200 patients were planned for inclu-
sion. Data were analysed on a per-protocol basis. This was
intentional, as the efficacy of preconditioning was hypoth-
esized to attenuate the damage from reperfusion, thus
requiring the patient to survive the vascular reconstruction.
Therefore, patients who died before vascular reconstruc-
tion were excluded from the per-protocol analysis. It was
not hypothesized that RIPC can stop haemorrhage.
Patient characteristics and operative data were compared
using the Mann–Whitney U test for continuous vari-
ables and the χ2 test for categorical variables. Categori-
cal outcome data were analysed by means of Fisher’s exact
test. Odds ratios (ORs) were calculated by logistic regres-
sion and plotted on a logarithmic scale in a forest plot.
Two-sided P< 0⋅050 was considered statistically signifi-
cant. SPSS® version 20.0 (IBM, Armonk, New York, USA)
was used for statistical analyses.
Results
A total of 200 patients with ruptured AAA were random-
ized. Thirty-nine patients died before surgery, and a further
13 died during the operation and were also excluded. A fur-
ther six patients were excluded owing to protocol viola-
tions, leaving 142 for per-protocol analysis (Fig. 1). This
resulted in 72 patients being assigned to RIPC and 70
as controls. From internal data records at the participat-
ing centres, it was ascertained that 403 potentially eligible
patients were treated between 2009 and 2014, of whom
only 200 were included in the study.
Of the 142 patients included, 127 (89⋅4 per cent) were
men. The mean(s.d.) age was 72⋅5(8⋅3) years. Baseline char-
acteristics were similar between the two groups (Table 1).
The previous medical record was unknown for six patients,
three in each group.
All patients had surgery under general anaesthesia.
Mean(s.d.) duration of operation was 175(72) min. There
were no significant differences between the two groups in
procedure duration, red blood cell transfusions, and use of
plasma and platelets (Table 2). There was no difference in
type of graft (tube/bifurcated) used.
Primary outcome
There were 26 MIs (36 per cent) in the RIPC group and
30 (43 per cent) in the control group during the hospital
admission (P = 0⋅502), an absolute difference of 7 per cent.
The OR for RIPC versus control was 0⋅75 (95 per cent c.i.
0⋅38 to 1⋅48; P = 0⋅411) (Fig. 2).
© 2018 The Authors. www.bjsopen.com BJS Open 2018; 2: 112–118
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Table 3 Outcome by per-protocol analysis
RIPC group Control group
(n=72) (n=70) P*
Myocardial infarction 26 (36) 30 (43) 0⋅502
30-day mortality 14 (19) 24 (34) 0⋅035
Cause of death
Cardiac 2 4
Multiple organ failure 3 7
Intestinal ischaemia 2 7
Pulmonary 1 3
Bleeding 4 1
Renal 2 1
Infection 0 1
Multiple organ failure 10 (14) 11 (16) 0⋅472
Intestinal ischaemia 5 (7) 12 (17) 0⋅052
Dialysis 14 (19) 17 (24) 0⋅310
Stroke 2 (3) 2 (3) 0⋅679
Values in parentheses are percentages. RIPC, remote ischaemic
preconditioning. *Fisher’s exact test.
Secondary outcomes
There were 14 deaths (19 per cent) in the RIPC group and
24 (34 per cent) in the control group by 30 days (P = 0⋅035),
an absolute risk reduction of 15 per cent. The OR for
RIPC versus control was 0⋅46 (95 per cent c.i. 0⋅22 to 0⋅99;
P = 0⋅048) by per-protocol analysis. Multiple organ failure
was identified in ten patients (14 per cent) in the RIPC
group and 11 (16 per cent) in the control group (P = 0⋅472).
Intestinal ischaemia developed in five patients (7 per cent)
in the RIPC group and 12 (17 per cent) in the control group
(P = 0⋅052). Acute kidney injury requiring dialysis occurred
in 14 (19⋅4 per cent) and 17 (24 per cent) respectively
(P = 0⋅310). There were two ischaemic strokes (3 per cent)
in each group.
Discussion
In this non-blinded RCT of patients undergoing open
repair for ruptured AAA, there was no significant difference
in rates of perioperative MI between those who received
RIPC and those who did not. The absolute risk reduc-
tion was 7 per cent in favour of RIPC. Previous random-
ized trials have focused on the effect of RIPC in patients
treated electively for an intact AAA with conflicting results,
reflecting study size and the fact that MI was not a primary
endpoint11,16–19. The present analysis is the first to evalu-
ate the effect of RIPC in the acute setting in patients with
ruptured AAA.
In earlier studies, the method of MI diagnosis could also
be questioned, although in a randomized study20, in which
MI was defined by concomitant ECG changes and rise in
troponin level, a non-significant absolute reduction of 5
per cent (RIPC 8 per cent, control 13 per cent) in the
incidence of MI was observed, a finding similar to that
reported here. The findings from these two studies are
much smaller than the expected 50 per cent relative risk
reduction estimated from the study by Ali and colleagues11,
even though the same American Heart Association defini-
tion of MI was used. In light of these observations, it is still
unclear whether RIPC has any benefit in decreasing the
incidence of MI among patients with AAA. The effects of
RIPC are arguably more modest than the initial assumed 50
per cent relative risk reduction, so the present and previous
studies may have insufficient sample sizes and be prone to
type II error.
The absolute reduction in mortality risk at 30 days
was 15 per cent, yielding an OR of 0⋅46 (95 per cent
c.i. 0⋅22 to 0⋅99). Two other studies11,17 found no differ-
ences in mortality, whereas a further study18 reported a
30-day mortality rate of 13⋅5 per cent with RIPC versus 0
per cent in a control group. The differences in observed
mortality between studies are not surprising, given that
patients in the present study underwent treatment for rup-
tured aneurysms, whereas all the other trials included only
patients with intact aneurysms undergoing elective surgery.
A recent review10 addressed other effects of RIPC,
including its influence on acute kidney injury and renal
impairment among patients undergoing elective AAA
repair. One study17 that looked at protective renal effects
as the primary outcome found that RIPC had no signif-
icant impact on kidney damage, when assessed by serum
creatinine levels and urinary output, whereas another11
reported a significant reduction in peak serum creati-
nine levels. No preoperative serum creatinine levels were
obtained for patients in the latter study owing to the acute
nature of patient recruitment, and so it was not possible to
differentiate acute from chronic renal insufficiency.
In the present study, intestinal ischaemia was also not
significantly reduced by RIPC. In another study16, where
intestinal ischaemia was evaluated by use of biomark-
ers, RIPC attenuated release of biomarkers of intesti-
nal ischaemia–reperfusion injury, with significantly lower
levels of endotoxin and a modest impact on the severity of
intestinal injury.
Regarding stroke, the effect of RIPC has been poorly
investigated. One study17 reported rates of 0 and 3 per cent
in RIPC and control groups, and another16 encountered no
strokes at all. The low incidence makes it difficult to draw
any conclusions about the effect of RIPC on stroke, but it
is interesting to note that these low numbers were similar
to those in the present analysis.
The present study has a number of limitations. The
issue of exclusion is important, as 58 (29⋅0 per cent) of
the randomized patients were excluded from the projected
© 2018 The Authors. www.bjsopen.com BJS Open 2018; 2: 112–118
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goal of 200, affecting the power of the study. A dropout
rate of only 10 per cent was assumed, which in retrospect
was too low. In addition, the power calculation was based
on a 50 per cent relative risk reduction for MI. However,
there turned out to be a much smaller reduction than
anticipated, so that no significant difference would have
been detected even if 100 patients survived in each arm.
Based on the present finding of a 7 per cent absolute
risk reduction in MI from 43 to 36 per cent, the trial
would have required a sample size of approximately 1200
patients. Of 403 potentially eligible patients, only 200
were included in the study. There were two reasons for
this. The study did not commence at the same time at all
three centres, and there was some reluctance at the start
on the part of surgeons and anaesthetists to accommodate
an experimental intervention in an acute procedure.
The fact that this study was based in an acute setting
also led to some limitations in baseline measurements.
The RIPC treatment was initialized during surgery, sim-
ilar to methods used in many elective studies, but the first
set of variables was collected immediately after operation.
Much of the focus of therapeutic conditioning has been
on the preischaemic stage for tissue protection, but recent
studies21–24 have shown that postconditioning may also
play an important role, thus questioning the role of tim-
ing in RIPC intervention. The acute setting may be an ideal
target for RIPC, but the varying and often extreme decom-
pensation of patients with ruptured AAA may have limited,
if any, potential gain from conditioning.
The type of anaesthesia was not standardized, which
could interfere with RIPC. A recent meta-analysis25 has
shown that some types of anaesthesia may protect against
ischaemia–reperfusion injury. The standard acute anaes-
thesia protocol in Denmark at all three participating
centres during the study period consisted of a propofol
and fentanyl-based anaesthesia, sometimes supported with
sevoflurane, at the discretion of the anaesthetist.
The lack of blinding of the surgeon is another limitation
that could have influenced outcomes, but was presumed not
to because the operating surgeon was not involved in data
collection, and the analysis was conducted unblinded. A
sham intervention and blinding of the surgeon would have
potentially limited the risk of confounding. Indeed, Li and
colleagues16 and Mouton et al.19 blinded surgeons to the
randomization in their studies, albeit in an elective setting.
The inclusion of non-consecutive patients and the risk of
selection bias are more concerning. Attempts were made
to overcome unequal inclusion among the three vascular
centres by using block randomization. The comparable
patient demographics suggest, at any rate, that patient
groups were similar.
Some medications could also have affected the results.
Sulphonylureas and nicorandil affect mitochondrial func-
tion. Sulphonylurea is not used in Denmark and nicorandil
only rarely, so it is unlikely that these drugs could have
affected the main result.
This RCT showed that, despite the high incidence of
MI, RIPC intervention had no significant effect, with an
absolute risk reduction of only 7 per cent. RIPC failed
to influence the incidence of multiple organ failure, acute
kidney injury, intestinal ischaemia and stroke, but there was
a statistically significant reduction in 30-day mortality. No
causal link with RIPC is apparent for this last finding.
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